Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

¥19.76As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300255Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR 8.78%
Div yield —
ROE (27.43%)
Biotechnology
Beta (5Y) 0.43
PE TTM —
TSR TTM (70.19%)
Mkt cap ¥18.16B
ROIC (5.12%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥20
2.80%
45.73%
Hold 0|0|8|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.31
0.31
0.34
0.34
30.26%
27.05%
36.66%
23.09%
Revenue¥B
2.370
2.308
2.357
2.400
12.45%
10.24%
6.92%
3.37%
Peers (US$2.722B)
Cap (US$)
PE
2.700B
36.65x
2.720B
12.41x
Capital
TTM
5Y
10Y
Leveragex
0.676
(0.016)
(0.016)
EBIT/Intx
0.700
0.050
0.056
Own earn%
53.59
45.34
7.98
Sh yield%
25.74
21.72
23.68
Owners
Insiders/Inst%
3.98
47.78
Short interest%
1.13
SBC / revenue%
5.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–28
$1 testx
—
Incr. ROIC%
22